SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (18608)2/9/1999 4:10:00 PM
From: VLAD  Respond to of 23519
 
RCM,

Thanks for your insight. I appreciate the information.



To: RCMac who wrote (18608)2/9/1999 4:13:00 PM
From: Mark A. Stang  Respond to of 23519
 
RCM

I agree with your jurisdictional anaysis. Pfizer can be sued anywhere they distribute their product. No opinion on the rest.

Mark



To: RCMac who wrote (18608)2/9/1999 4:30:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
RCM,

Is there an internet sight where I can see some of the lawsuits filed against Pfizer in regards to the adverse effects caused by Viagra?



To: RCMac who wrote (18608)2/9/1999 7:22:00 PM
From: Greg22  Read Replies (1) | Respond to of 23519
 
<<2) are dubious about proving causality, in light of the sort of analysis outlined in JennyLouise's post #18606, and >>

I would not be so sure about lack of causality. This may be why Vivus execs are buying. Could they know something that the general public does not? Remember, Vivus considered systemic PDE5 inhibitors at first, but then discarded the idea as being to dangerous.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News